2018 News

12.25.2018 Information

Corporate Social Responsibility (CSR) page on our website has been updated

11.27.2018 Press Release

Santen and Ube Industries Announce Launch of Glaucoma and Ocular Hypertension Treatment EYBELIS Ophthalmic Solution 0.002% in Japan

11.07.2018 Press Release

Santen Reports the 2nd Quarter Fiscal 2018 Consolidated Performance

10.23.2018 Information

Corporate Social Responsibility (CSR) page on our website has been updated

09.25.2018 Press Release

Santen Announces Drug Discovery and Development Agreement with PeptiDream

09.25.2018 Press Release

Santen Donates to the 2018 Hokkaido Eastern Iburi Earthquake Relief Efforts in Japan

09.21.2018 Press Release

Santen and Ube Industries Announce Receipt of Manufacturing and Marketing Approval for Glaucoma and Ocular Hypertension Treatment EYBELIS in Japan

09.21.2018 Press Release

Santen Files for Manufacturing and Marketing Approval of Anti-Allergy Ophthalmic Drug Candidate DE-114A (JAN: Epinastine Hydrochloride)

09.13.2018 Press Release

Personnel Changes of Corporate Officer

09.12.2018 Press Release

Personnel Changes of Representative Director of the Board

08.01.2018 Press Release

Santen Reports the 1st Quarter Fiscal 2018 Consolidated Performance

07.26.2018 Press Release

Notice on Completion of Payment for Issuance of New Shares Under Restricted Stock-linked Remuneration Program

07.17.2018 Press Release

Santen Donates to Japan Flood and Landslide Relief Efforts

07.10.2018 Press Release

Santen Receives Marketing Authorisation from the European Commission for DE-076C (Verkazia) as an Orphan Medicinal Product

06.28.2018 Information

Corporate Social Responsibility (CSR) page on our website has been updated

06.26.2018 Press Release

Notice on the Issuance of New Shares Under Restricted Stock-Linked Remuneration Program

06.04.2018 Press Release

Santen Announces Medium-Term Plan (MTP2020)

05.09.2018 Press Release

Notice on the Introduction of a New Stock-Linked Remuneration Program and Change to Director Remuneration

05.09.2018 Press Release

Notice of Board of Director and Corporate Auditor Nominations

05.09.2018 Press Release

Santen Reports Fiscal 2017 Consolidated Performance

03.29.2018 Information

CSR page on our website has been updated

03.14.2018 Press Release

Notice of Corporate Officer Appointments

02.23.2018 Press Release

Santen to Conduct a Public Awareness Campaign for Glaucoma During World Glaucoma Week March 11 - 17

02.20.2018 Information

Santen Awarded for Corporate Governance

02.20.2018 Press Release

Santen Announces Appointment of New President

02.06.2018 Press Release

Santen Reports the 3rd Quarter Fiscal 2017 Consolidated Performance